Sodium Zirconium Cyclosilicate
Showing 1 - 25 of 3,083
Hyperkalemia Trial in Alexandria (sodium zirconium cyclosilicate (SZC), sodium polystyrene sulfonate)
Not yet recruiting
- Hyperkalemia
- sodium zirconium cyclosilicate (SZC)
- sodium polystyrene sulfonate
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Sep 7, 2023
Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5, Hyperkalemia Trial in Stockholm (sodium zirconium cyclosilicate
Recruiting
- Chronic Kidney Disease stage4
- +2 more
- sodium zirconium cyclosilicate and healthy diet
-
Stockholm, SwedenKarolinska Institutet
Jan 16, 2023
Sodium Zirconium Cyclosilicate, Hyperkalemia, Hyperparathyroidism, Secondary Trial (Sodium zirconium cyclosilicate)
Completed
- Sodium Zirconium Cyclosilicate
- +2 more
- Sodium zirconium cyclosilicate
- (no location specified)
May 16, 2022
A Multicenter, Prospective, Non-interventional Cohort Study to
Recruiting
- Hyperkalaemia
-
Dalian, ChinaThe First Affiliated Hospital of Dalian Medical University
Jun 14, 2022
Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)
Recruiting
- Heart Failure
- Hyperkalemia
- Sodium zirconium cyclosilicate
- Placebo
-
Gothenburg, SwedenSahlgrenska University Hospital-Ostra Hospital
Sep 20, 2021
Hyperkalaemia Trial in West Palm Beach (Sodium Zirconium Cyclosilicate (SZC), Enhanced dietary advice, Standard dietary advice
Terminated
- Hyperkalaemia
- Sodium Zirconium Cyclosilicate (SZC)
- +2 more
-
West Palm Beach, FloridaResearch Site
Feb 21, 2022
Acute Hyperkalemia, Oral Potassium Binders Trial in Orange (Polyethylene Glycol 3350, Sodium Polystyrene Sulfonate Oral
Recruiting
- Acute Hyperkalemia
- Oral Potassium Binders
- Polyethylene Glycol 3350
- +3 more
-
Orange, CaliforniaUniversity of California, Irvine Medical Center
Nov 2, 2022
CKD, Diabetes, Type 2, Hyperkalemia Trial in London (Sodium Zirconium Cyclosilicate, Placebo)
Not yet recruiting
- CKD
- +2 more
- Sodium Zirconium Cyclosilicate
- Placebo
-
London, Uk, United KingdomKieran Mccafferty
Mar 17, 2022
Hyperkalemia Trial in China, India (Sodium Zirconium Cyclosilicate 5g, Sodium Zirconium Cyclosilicate 10g, Placebo)
Completed
- Hyperkalemia
- Sodium Zirconium Cyclosilicate 5g
- +2 more
-
Beijing, China
- +31 more
Oct 11, 2022
Hyperkalaemia, Chronic Kidney Disease Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), Local standard of care)
Recruiting
- Hyperkalaemia
- Chronic Kidney Disease
- Sodium Zirconium Cyclosilicate (SZC)
- Local standard of care
-
Belgium, Belgium
- +37 more
Aug 8, 2022
Hyperkalemia Trial in China (Sodium Zirconium Cyclosilicate, Placebo)
Completed
- Hyperkalemia
- Sodium Zirconium Cyclosilicate
- Placebo
-
Baotou, China
- +35 more
Feb 21, 2022
Hyperkalaemia, Metabolic Acidosis, Chronic Kidney Disease Trial in Puerto Rico, United States (Sodium zirconium cyclosilicate,
Terminated
- Hyperkalaemia
- +2 more
- Sodium zirconium cyclosilicate
- Placebo
-
Florence, Alabama
- +29 more
Dec 7, 2022
Chronic Kidney Diseases, Hyperkalemia Trial in Boston (Sodium Zirconium Cyclosilicate Oral Product)
Unknown status
- Chronic Kidney Diseases
- Hyperkalemia
- Sodium Zirconium Cyclosilicate Oral Product
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 27, 2021
Heart Failure Trial in Worldwide (Sodium Zirconium Cyclosilicate, Placebo)
Terminated
- Heart Failure
- Sodium Zirconium Cyclosilicate
- Placebo
-
National City, California
- +75 more
May 20, 2021
Renal Insufficiency, Chronic, Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), Placebo, Lisinopril)
Recruiting
- Renal Insufficiency, Chronic
- Hyperkalemia
- Sodium Zirconium Cyclosilicate (SZC)
- +4 more
-
Tucson, Arizona
- +281 more
Jan 10, 2023
Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (SZC), SZC Placebo)
Recruiting
- Hyperkalemia
- Sodium Zirconium Cyclosilicate (SZC)
- SZC Placebo
-
Huntsville, Alabama
- +355 more
Feb 1, 2023
Hyperkalemia Trial in United States (LOKELMA 5 GM Powder for Oral Suspension)
Recruiting
- Hyperkalemia
- LOKELMA 5 GM Powder for Oral Suspension
-
La Jolla, California
- +4 more
Sep 7, 2022
Hyperkalaemia, Heart Failure With Reduced Ejection Fraction Trial in Worldwide (Sodium zirconium cyclosilicate, Placebo,
Recruiting
- Hyperkalaemia
- Heart Failure With Reduced Ejection Fraction
- Sodium zirconium cyclosilicate
- +2 more
-
Fairhope, Alabama
- +126 more
Jan 20, 2023
Hyperkalemia Trial in Worldwide (Sodium Zirconium Cyclosilicate (ZS) 10g, Sodium Zirconium Cyclosilicate (ZS) 5g, Placebo)
Completed
- Hyperkalemia
- Sodium Zirconium Cyclosilicate (ZS) 10g
- +2 more
-
Chiba-shi, Japan
- +44 more
Aug 6, 2020
Type 2 Diabetes With Kidney Complications Trial in Gentofte (LOKELMA 5 GM Powder for Oral Suspension, Placebos)
Unknown status
- Type 2 Diabetes Mellitus With Kidney Complications
- LOKELMA 5 GM Powder for Oral Suspension
- Placebos
-
Gentofte, DenmarkSteno Diabetes Center Copenhagen
Oct 14, 2019
Hyperkalemia Trial in Worldwide (Placebo, Sodium Zirconium Cyclosilicate (ZS))
Completed
- Hyperkalemia
- Placebo
- Sodium Zirconium Cyclosilicate (ZS)
-
Los Angeles, California
- +52 more
Feb 10, 2020
Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in London (Lokelma Oral Product)
Recruiting
- Chronic Kidney Diseases
- +4 more
- Lokelma Oral Product
-
London, United KingdomSt Georges, University of London
Feb 16, 2022